This claim was settled in March 1996 with an injunction, requiring CTCA to discontinue use of any unsubstantiated claims in its advertising.[11] CTCA is also required to have proven, scientific evidence for all statements regarding the safety, success rates, endorsements, and benefits of its cancer treatments. CTCA was also required to follow various steps in order to report compliance to the FTC per the settlement.